Viewing Study NCT04193293


Ignite Creation Date: 2025-12-25 @ 1:08 AM
Ignite Modification Date: 2026-01-01 @ 3:39 AM
Study NCT ID: NCT04193293
Status: TERMINATED
Last Update Posted: 2023-09-21
First Post: 2019-12-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck Cancer
Sponsor: SecuraBio
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: VS-0145-130
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators